Suzanne Tollerud Ildstad (born May 20, 1952, in Hennepin County, Minnesota) is an American physician and medical researcher.

[1] She is the Chief Scientific Officer and founding CEO of Talaris Therapeutics (her discovery of tolerogenic graft facilitating cells led to the formation of the company).

She is also the Jewish Hospital Distinguished Professor of Transplantation Research, Director of the Institute for Cellular Therapeutics,[3] Professor in the Department of Surgery with associate appointments in the Departments of Physiology & Biophysics and Microbiology & Immunology at the University of Louisville School of Medicine.

[4] After earning her medical degree at Mayo Clinic Medical School, Ildstad did her surgical residency at Massachusetts General Hospital, an immunology fellowship at the National Institutes of Health, and a pediatric surgery/transplant fellowship at Cincinnati Children's Hospital.

You can help Wikipedia by expanding it.This biographical article related to a physician in the United States is a stub.